They are also, whether symptomatic or not, six times more likely to die within ten years when compared to patients without the disease.

This excess mortality exists even if coronary artery disease is not clinically present, and makes the treatment of PVD a highly important and pressing topic.

Pharmacological Therapies for Peripheral Vascular Disease presents all of the currently available clinical information for treating PVD patients effectively.